RecallDepth
Class II Ongoing

Duloxetine Delayed-Release Capsules, USP, 30 mg, Rx only, a) 30 count (NDC 68001-414-04) and b) 1,000 count (NDC 68001-414-08) bottles, Manufactured by: Aurobindo Pharma Limited, Hyderabad-500 090, India, For BluePoint Laboratories

Company
Amerisource Health Services Llc
Recall Initiated
November 14, 2024
Posted
December 11, 2024
Recall Number
D-0100-2025
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
23,490 bottles
Firm Location
Columbus, OH, United States

Reason for Recall

CGMP Deviations: Presence of N-nitroso-duloxetine impurity above the recommended interim limit

Distribution

PA, OH, PR

Lot / Code Info

a) 30 count; Lot, expiry: DT3023019B, DT3023020A, exp 01/31/2025 b) 1000 count; Lot, expiry: DTB23098A, exp 08/31/2025

More recalls by Amerisource Health Services Llc

View all recalls by this company →

Other recent Class II Drug recalls